Spineart and eCential Robotics announce FDA clearance of PERLA® App for use with Op.nTM robotic navigation platform
FOR IMMEDIATE RELEASESpineart and eCential Roboticsannounce FDA clearance of PERLA® App for use with Op.nTM robotic navigation platformDallas, ...
Indiatimes26d
Opiod row: Aveo Pharma says drug cleared by state authorities; govt says not approved
Mumbai-based Aveo Pharmaceuticals, however, claimed the combination is approved by the relevant state drug authorities and is exported under necessary approval from the assistant drug controllers with ...
Pharmaceutical Technology26d
FDA approves Mirum’s Ctexli for cerebrotendinous xanthomatosis
Mirum Pharmaceuticals’ Ctexli (chenodiol) has gained US Food and Drug Administration (FDA) approval for treating adults with cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease. It is ...
verywellhealth27d
List of Approved HIV Antiretroviral Drugs
As of 2022, the Food and Drug Administration has approved 26 individual drug agents and 22 fixed-dosed combination (FDC) drugs comprised of two or more antiretrovirals. This includes the first ...
USA Today28d
Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list
Feb 21 (Reuters) - The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's NOVOb.CO popular weight-loss and diabetes drugs, Wegovy and ...
CNN28d
Ozempic and Wegovy are no longer in shortage, FDA says
“We are pleased the FDA has declared that supply of the only real, FDA-approved semaglutide medicines is resolved, affirming that Novo Nordisk is meeting or exceeding current and projected ...
The Scarborough News28d
Plan to convert Whitby art gallery and café into residential property gets approval
An art gallery and café in the town centre of Whitby will be converted into a residential property after plans were approved by North Yorkshire Council. Did you know with an ad-lite subscription to ...
optometryadvisor1mon
FDA Drug Approval Decisions Expected in March 2025
The FDA is reviewing the application for bentracimab for use as a ticagrelor reversal agent in patients with uncontrolled bleeding or in those who require urgent surgery or invasive procedure.